Aemetis (NASDAQ:AMTX) Share Price Passes Below 200 Day Moving Average – Should You Sell?

Aemetis, Inc (NASDAQ:AMTX) shares passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $2.13 and traded as low as $1.8750. Aemetis shares last traded at $1.88, with a volume of 475,755 shares traded.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on AMTX shares. Ascendiant Capital Markets boosted their price target on Aemetis from $21.00 to $22.00 and gave the company a “buy” rating in a research note on Friday, May 22nd. Weiss Ratings restated a “sell (e+)” rating on shares of Aemetis in a research report on Friday, July 17th. Finally, Wall Street Zen raised shares of Aemetis from a “sell” rating to a “hold” rating in a report on Saturday, August 22nd. One research analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $11.88.

Aemetis Trading Up 14.9%

The firm has a 50-day moving average of $1.76 and a two-hundred day moving average of $2.13. The firm has a market capitalization of $155.89 million, a P/E ratio of -2.37 and a beta of 1.47.

Aemetis (NASDAQ:AMTX) last issued its earnings results on Thursday, August 6th. The specialty chemicals company reported ($0.13) EPS for the quarter, topping the consensus estimate of ($0.29) by $0.16. The business had revenue of $62.70 million for the quarter, compared to analyst estimates of $67.69 million. On average, sell-side analysts anticipate that Aemetis, Inc will post -0.89 EPS for the current fiscal year.

Institutional Trading of Aemetis

A number of hedge funds have recently made changes to their positions in AMTX. J. Derek Lewis & Associates Inc. bought a new position in shares of Aemetis during the fourth quarter valued at $322,000. Bank of New York Mellon Corp bought a new position in shares of Aemetis during the second quarter worth about $283,000. Bank of America Corp DE raised its position in shares of Aemetis by 148.3% during the first quarter. Bank of America Corp DE now owns 101,486 shares of the specialty chemicals company’s stock worth $324,000 after acquiring an additional 60,611 shares during the last quarter. Renaissance Technologies LLC acquired a new position in shares of Aemetis in the first quarter worth approximately $272,000. Finally, Caitong International Asset Management Co. Ltd bought a new stake in Aemetis in the fourth quarter valued at approximately $115,000. 27.02% of the stock is owned by institutional investors and hedge funds.

About Aemetis

Aemetis, Inc is a renewable fuels and biochemicals company focused on developing and operating technologies that reduce greenhouse gas emissions. Its activities include the production of renewable natural gas, renewable fuels, and other low-carbon products derived from agricultural and organic waste.

The company’s Aemetis Biogas business develops and operates dairy-waste digesters and related infrastructure in California’s Central Valley. These systems capture methane from dairy manure and convert it into renewable natural gas for transportation and other energy applications.